[
  {
    "ts": null,
    "headline": "A Closer Look at Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Stability",
    "summary": "Vertex Pharmaceuticals (VRTX) shares have been fairly steady recently, as investors digest the company’s financial performance over the past month. The stock is up 8% since early May. This reflects a cautious optimism about ongoing growth in the biotech sector. See our latest analysis for Vertex Pharmaceuticals. While Vertex Pharmaceuticals’ 1-day and 1-week share price returns have been positive, it is the rebound since early May that stands out, hinting at growing investor confidence...",
    "url": "https://finnhub.io/api/news?id=31209ff08456263b00bff5daa8e5d49a801176d550b3d8ee399afafa908c9d8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760767698,
      "headline": "A Closer Look at Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Stability",
      "id": 137165137,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals (VRTX) shares have been fairly steady recently, as investors digest the company’s financial performance over the past month. The stock is up 8% since early May. This reflects a cautious optimism about ongoing growth in the biotech sector. See our latest analysis for Vertex Pharmaceuticals. While Vertex Pharmaceuticals’ 1-day and 1-week share price returns have been positive, it is the rebound since early May that stands out, hinting at growing investor confidence...",
      "url": "https://finnhub.io/api/news?id=31209ff08456263b00bff5daa8e5d49a801176d550b3d8ee399afafa908c9d8c"
    }
  }
]